Wed, November 3, 2021
Tue, November 2, 2021
Mon, November 1, 2021
Sun, October 31, 2021
Sat, October 30, 2021
Fri, October 29, 2021
Thu, October 28, 2021

Matthew Harrison Maintained (ABBV) at Buy with Increased Target to $124 on, Nov 1st, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-124-on-nov-1st-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $116 to $124 on, Nov 1st, 2021.

Matthew has made no other calls on ABBV in the last 4 months.



There are 3 other peers that have a rating on ABBV. Out of the 3 peers that are also analyzing ABBV, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $119 on, Monday, August 2nd, 2021


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Steve Scala of "TD Cowen" Maintained at Buy with Increased Target to $130 on, Monday, August 23rd, 2021
  • Robyn Karnauskas of "Truist Securities" Initiated at Strong Buy and Held Target at $118 on, Monday, July 26th, 2021

Publication Contributing Sources